BGDO Annual Meeting 2022

15 janvier 2022 Virtuel

The  Virtual BGDO annual meeting on Saturday 15 January will mainly focus on Immunotherapy in G-I Oncology: more specifically on Efficacy, Toxicity and Failures, Health Economics. We will also discuss the Perspectives of Immune Therapies in “G-I Cancers”.



8.30   BGDO General Assembly

Session 1

Chairs: Veerle Casneuf | Jean-Luc Van Laethem – ULB Erasme, Brussels

9:00      Efficacy & Failures across tumour types  

  • Standard recommendation in Belgium: MSIH CRC, Liver Cancer, Upper GI  Marc Peeters – UZ Antwerp
  • Failures and upcoming standards Eric Van Cutsem – UZ Leuven

10:00     Toxicity of immunotherapies  Karen Geboes – UZ Gent

10:30   Break

 Session 2

Chairs: Alain Hendlisz- Institut Bordet Brussels  | Marc Van de Eynde – UCL Saint-Luc, Brussels

10:45    Health Economics  

11:30    Perspectives of Immune Therapies in “G-I Cancers”   

  • Fundamental Pierre Coulie ~ UCL Saint-Luc, Brussels
  • Future perspectives of Immunotherapy in upper G.I. cancers Markus Möhler – Medizinische Klinik Mainz

12:30  Closing remarks  Marc Peeters, BGDO chairman


Site internet :